Teva Pharmaceuticals Generic Medications

Teva Pharmaceutical Industries Ltd. is a global leader in the pharmaceutical sector, recognized primarily as the world's largest manufacturer of generic medicines. The brand's history is rooted in the early 20th century in Israel, where it grew from a small local distributor into a multinational powerhouse through strategic acquisitions of major companies like IVAX, Barr, and Actavis.

The manufacturing footprint of Teva is vast and geographically diverse. The company operates numerous production facilities across the globe, including significant hubs in Israel, the United States, Hungary, Germany, Croatia, India, and Mexico. This distributed network allows Teva to supply thousands of different medicinal products to markets worldwide, ranging from common over-the-counter pain relief to complex specialty treatments for central nervous system disorders and respiratory conditions.

Ownership of Teva is public, with its shares traded on both the New York Stock Exchange and the Tel Aviv Stock Exchange. While it remains headquartered in Tel Aviv, Israel, it functions as a global enterprise with a strong corporate presence in New Jersey, USA. As of 2026, Teva continues to focus on its 'Pivot to Growth' strategy, emphasizing both its leadership in generics and its expanding portfolio of innovative biopharmaceuticals.